Skip to search formSkip to main contentSkip to account menu

Palmar-plantar erythrodysesthesia syndrome

Known as: Chemotherapy-Induced Palmoplantar Erythrodysesthesias, Palmoplantar Erythrodysesthesias, Chemotherapy-Induced, Palmoplantar Erythrodysesthesia, Chemotherapy-Induced 
Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
SummaryBackground This phase I study evaluated the safety, tolerability and preliminary efficacy of sorafenib combined with… 
Highly Cited
2012
Highly Cited
2012
This study explored the efficacy, tolerability, and survival benefits of using sorafenib in patients with Child‐Pugh class B (CPB… 
Review
2012
Review
2012
Background: Eribulin is a non-taxane microtubule dynamics inhibitor. In a previous Phase III trial, eribulin demonstrated a… 
Highly Cited
2010
Highly Cited
2010
There is no effective systemic therapy for patients with advanced hepatocellular carcinoma (HCC) except liver transplantation… 
2010
2010
The treatment of AIDS-related malignancies raises specific pharmacological issues in patients receiving highly active… 
Highly Cited
2004
Highly Cited
2004
We have evaluated the efficacy and safety of the combination of capecitabine and vinorelbine in metastatic breast cancer (MBC… 
Highly Cited
1994
Highly Cited
1994
ObjectiveThe authors present their 35-year experience with intra-arterial chemotherapeutic regional perfusion of 1139 patients… 
1985
1985
Excerpt To the editor: I read with interest the article by Lokich and Moore (1) on the palmar-plantar erythrodysesthesia syndrome… 
Highly Cited
1982
Highly Cited
1982
Systemic scleroderma and localized scleroderma (morphea) show comparable changes on skin biopsy specimens, and a distinction has…